Shooting Cancer Highlights: precision oncology in motion. ASCO 2025 edition
More than half the sessions at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting touched on immunotherapies, cell and gene therapies, and antibody-drug conjugates (ADCs) whereas about 10% of the content was focused on traditional modalities of chemotherapy, radiation, and surgery. Here, we report on data presented at the meeting and coming from […]